Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Ronda Henry-Tillman

Concepts (256)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
39
2024
1198
4.650
Why?
Early Detection of Cancer
6
2020
162
2.320
Why?
Ultrasonography, Mammary
8
2020
61
1.990
Why?
Mass Screening
3
2020
343
1.490
Why?
Colorectal Neoplasms
4
2018
256
1.490
Why?
Healthcare Disparities
3
2017
280
1.070
Why?
Mastectomy
13
2019
142
1.060
Why?
Mastectomy, Segmental
7
2018
93
1.030
Why?
Sentinel Lymph Node Biopsy
10
2015
118
0.990
Why?
Community Health Planning
3
2018
26
0.960
Why?
Ultrasonography, Interventional
5
2020
137
0.820
Why?
Biopsy, Needle
10
2015
179
0.820
Why?
Focus Groups
1
2024
193
0.810
Why?
Neoplasm Staging
14
2024
738
0.800
Why?
Biopsy, Large-Core Needle
3
2020
33
0.790
Why?
Female
55
2024
27053
0.760
Why?
Genetic Counseling
1
2022
41
0.740
Why?
Neoplasms
5
2015
1248
0.740
Why?
Lymph Nodes
7
2015
256
0.730
Why?
Health Status Disparities
3
2015
201
0.730
Why?
Patient Education as Topic
1
2024
332
0.700
Why?
Image Interpretation, Computer-Assisted
1
2020
105
0.670
Why?
Middle Aged
40
2024
12579
0.650
Why?
Image-Guided Biopsy
2
2020
33
0.640
Why?
Hematoma
4
2018
64
0.630
Why?
Surgery, Computer-Assisted
2
2018
53
0.620
Why?
Polymorphism, Single Nucleotide
2
2018
468
0.610
Why?
Humans
60
2024
50419
0.610
Why?
Mandatory Programs
1
2018
21
0.580
Why?
Adiposity
1
2019
137
0.570
Why?
Faculty, Medical
3
2021
91
0.560
Why?
Health Care Costs
1
2018
171
0.550
Why?
Adult
32
2024
13561
0.550
Why?
Aged
31
2024
9738
0.550
Why?
Insurance Coverage
1
2018
111
0.530
Why?
Disease Management
1
2018
179
0.520
Why?
Diagnostic Imaging
1
2018
182
0.510
Why?
Minority Groups
3
2015
130
0.500
Why?
Arkansas
9
2018
1974
0.490
Why?
Retrospective Studies
19
2022
6274
0.470
Why?
Physicians
1
2018
235
0.460
Why?
Health Planning Councils
1
2014
6
0.440
Why?
Community-Based Participatory Research
2
2015
198
0.430
Why?
Health Policy
1
2014
146
0.410
Why?
Rural Population
1
2017
556
0.400
Why?
Follow-Up Studies
11
2018
2231
0.400
Why?
Aged, 80 and over
14
2018
3233
0.390
Why?
Qualitative Research
3
2024
351
0.380
Why?
Community Networks
2
2015
49
0.380
Why?
Primary Health Care
2
2024
363
0.370
Why?
Community-Institutional Relations
1
2011
46
0.370
Why?
Carcinoma, Ductal, Breast
4
2015
90
0.360
Why?
Carcinoma, Lobular
2
2015
32
0.360
Why?
Population Surveillance
1
2012
163
0.350
Why?
Physicians, Women
2
2021
21
0.350
Why?
Neoplasm Recurrence, Local
6
2014
622
0.330
Why?
Women's Health
1
2010
84
0.320
Why?
Health Education
2
2008
153
0.320
Why?
Needs Assessment
2
2024
138
0.320
Why?
Medical Oncology
1
2010
97
0.310
Why?
Breast Diseases
4
2018
26
0.300
Why?
Health Knowledge, Attitudes, Practice
1
2012
485
0.290
Why?
Nipples
5
2013
33
0.280
Why?
Schools, Medical
2
2020
70
0.280
Why?
Axilla
6
2015
92
0.280
Why?
Socioeconomic Factors
3
2018
591
0.280
Why?
Morbidity
2
2018
130
0.280
Why?
Health Services Accessibility
1
2011
426
0.260
Why?
Physician-Patient Relations
2
2012
143
0.260
Why?
Catheter Ablation
4
2014
120
0.250
Why?
Mammaplasty
3
2013
44
0.250
Why?
Prognosis
9
2024
1974
0.250
Why?
Mentors
1
2006
55
0.240
Why?
Lymphatic Metastasis
7
2015
221
0.240
Why?
Survivors
2
2024
126
0.240
Why?
Occult Blood
2
2017
22
0.240
Why?
United States
7
2022
5005
0.230
Why?
Young Adult
5
2024
4075
0.230
Why?
Magnetic Resonance Imaging
5
2014
1546
0.220
Why?
Referral and Consultation
2
2024
287
0.210
Why?
Education, Medical, Graduate
2
2022
214
0.210
Why?
Technetium Tc 99m Sulfur Colloid
4
2008
31
0.200
Why?
Male
13
2022
25866
0.200
Why?
Empathy
1
2002
47
0.190
Why?
Problem-Based Learning
1
2002
49
0.190
Why?
Atrial Fibrillation
1
2024
188
0.180
Why?
Emotions
1
2023
167
0.180
Why?
Breast
2
2020
87
0.180
Why?
Genetic Testing
1
2022
120
0.180
Why?
Democratic Republic of the Congo
1
2020
4
0.180
Why?
Dermatologic Surgical Procedures
3
2013
35
0.180
Why?
Counseling
1
2022
132
0.180
Why?
Combined Modality Therapy
4
2018
640
0.180
Why?
Feasibility Studies
2
2020
389
0.180
Why?
Biopsy, Fine-Needle
1
2020
108
0.170
Why?
Research Support as Topic
1
2020
45
0.170
Why?
Students, Medical
1
2002
157
0.170
Why?
General Surgery
1
2021
105
0.160
Why?
Obesity
1
2008
1123
0.160
Why?
Surgical Flaps
2
2019
110
0.160
Why?
Prospective Studies
10
2024
2378
0.160
Why?
Incidence
2
2024
1027
0.150
Why?
Patient Satisfaction
2
2019
276
0.150
Why?
Radiopharmaceuticals
4
2008
202
0.140
Why?
Adipose Tissue
1
2019
192
0.140
Why?
Logistic Models
2
2018
901
0.140
Why?
Diagnosis, Differential
1
2020
1029
0.140
Why?
Rural Health
1
2017
89
0.140
Why?
Lymphatic Vessels
2
2008
53
0.130
Why?
Odds Ratio
1
2018
550
0.130
Why?
Internship and Residency
1
2022
443
0.130
Why?
Zambia
3
2024
3
0.130
Why?
Mammography
1
2016
100
0.130
Why?
Rural Health Services
1
2018
170
0.130
Why?
Genetic Predisposition to Disease
1
2018
507
0.120
Why?
Cytodiagnosis
2
2013
41
0.120
Why?
Risk Assessment
2
2018
1268
0.120
Why?
Case-Control Studies
1
2018
1152
0.120
Why?
Cross-Sectional Studies
3
2021
1601
0.120
Why?
National Cancer Institute (U.S.)
1
2015
31
0.120
Why?
Survival Rate
1
2017
906
0.120
Why?
Uterine Cervical Neoplasms
1
2017
275
0.110
Why?
Algorithms
1
2018
624
0.110
Why?
Career Mobility
2
2021
28
0.110
Why?
Patient Care Planning
1
2013
66
0.110
Why?
Carcinoma, Intraductal, Noninfiltrating
1
2013
45
0.100
Why?
Education, Medical
2
2006
109
0.100
Why?
Monitoring, Intraoperative
3
2014
54
0.100
Why?
Sigmoidoscopy
1
2012
10
0.100
Why?
Reagent Kits, Diagnostic
1
2012
16
0.100
Why?
Health Services
1
2012
65
0.090
Why?
Reproducibility of Results
1
2015
1181
0.090
Why?
Colonoscopy
1
2012
100
0.090
Why?
Lymph Node Excision
4
2008
131
0.090
Why?
Treatment Outcome
9
2017
5265
0.090
Why?
Feces
1
2012
138
0.090
Why?
Receptors, Estrogen
2
2015
132
0.090
Why?
Pancreatic Neoplasms
1
2013
204
0.090
Why?
Lymphedema
2
2008
46
0.090
Why?
Fructose
1
2010
22
0.090
Why?
Clinical Competence
1
2013
403
0.090
Why?
Patient Compliance
1
2012
232
0.090
Why?
Carbon
1
2010
54
0.080
Why?
Registries
1
2013
565
0.080
Why?
Risk Factors
3
2024
3712
0.080
Why?
History, 21st Century
1
2010
57
0.080
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2015
997
0.080
Why?
Carcinoma in Situ
2
2006
73
0.080
Why?
Patient Acceptance of Health Care
1
2012
342
0.070
Why?
Delivery of Health Care
1
2011
305
0.070
Why?
Models, Theoretical
2
2006
168
0.070
Why?
Prochlorperazine
1
2006
6
0.070
Why?
Postoperative Nausea and Vomiting
1
2006
20
0.060
Why?
Sensitivity and Specificity
3
2004
855
0.060
Why?
Antiemetics
1
2006
31
0.060
Why?
Education, Medical, Continuing
1
2006
70
0.060
Why?
Receptor, erbB-2
1
2006
73
0.060
Why?
Body Weights and Measures
1
2005
17
0.060
Why?
Biopsy
2
2004
588
0.060
Why?
Predictive Value of Tests
2
2013
924
0.060
Why?
Intraoperative Care
2
2003
52
0.060
Why?
Gadolinium
1
2005
45
0.060
Why?
Interprofessional Relations
1
2006
82
0.060
Why?
Tissue Expansion Devices
1
2004
3
0.060
Why?
Neuromuscular Agents
1
2004
8
0.060
Why?
Neoadjuvant Therapy
2
2017
119
0.060
Why?
Botulinum Toxins, Type A
1
2004
14
0.060
Why?
Imaging, Three-Dimensional
1
2005
151
0.060
Why?
Contrast Media
1
2005
191
0.060
Why?
Life Expectancy
1
2024
33
0.060
Why?
Cytological Techniques
1
2003
14
0.050
Why?
Anthracyclines
1
2024
29
0.050
Why?
Neoplasms, Multiple Primary
1
2003
42
0.050
Why?
Neoplasm Grading
2
2014
122
0.050
Why?
Pain, Postoperative
1
2004
163
0.050
Why?
Preoperative Care
3
2014
170
0.050
Why?
Surgical Instruments
1
2002
27
0.050
Why?
Humanism
1
2002
8
0.050
Why?
Foreign-Body Migration
1
2002
32
0.050
Why?
Life Change Events
1
2002
35
0.050
Why?
Confidence Intervals
1
2002
155
0.050
Why?
Career Choice
1
2002
112
0.050
Why?
Program Development
1
2002
163
0.050
Why?
Sexism
1
2021
10
0.050
Why?
Image Processing, Computer-Assisted
1
2002
245
0.040
Why?
Leadership
1
2021
100
0.040
Why?
Neoplasm Invasiveness
2
2010
269
0.040
Why?
Vacuum
2
2011
13
0.040
Why?
Curriculum
1
2002
393
0.040
Why?
Stereotaxic Techniques
2
2010
38
0.040
Why?
Angiopoietin-2
1
2017
15
0.030
Why?
Angiopoietin-1
1
2017
16
0.030
Why?
Receptor, TIE-2
1
2017
16
0.030
Why?
Fibroblast Growth Factor 2
1
2017
35
0.030
Why?
Clinical Trials, Phase II as Topic
1
2017
46
0.030
Why?
Gene Frequency
1
2017
93
0.030
Why?
Injections, Intralesional
2
2008
31
0.030
Why?
Matrix Metalloproteinase 9
1
2017
88
0.030
Why?
Adolescent
3
2013
6453
0.030
Why?
Vascular Endothelial Growth Factor A
1
2017
180
0.030
Why?
Guidelines as Topic
1
2016
110
0.030
Why?
Regression Analysis
1
2017
376
0.030
Why?
Neovascularization, Pathologic
1
2017
155
0.030
Why?
Coloring Agents
2
2007
67
0.030
Why?
Radionuclide Imaging
2
2007
116
0.030
Why?
Educational Status
1
2016
225
0.030
Why?
Genotype
1
2017
525
0.030
Why?
Taxoids
1
2015
37
0.030
Why?
Receptors, Progesterone
1
2015
64
0.030
Why?
Cohort Studies
2
2011
1451
0.030
Why?
Cyclophosphamide
1
2015
168
0.030
Why?
Touch
1
2013
25
0.030
Why?
Ultrasonography, Doppler
1
2014
41
0.030
Why?
Carcinoma
1
2015
137
0.030
Why?
Angiogenesis Inhibitors
1
2015
183
0.030
Why?
Antibodies, Monoclonal, Humanized
1
2015
224
0.030
Why?
Disease-Free Survival
1
2014
439
0.030
Why?
Kaplan-Meier Estimate
1
2014
462
0.020
Why?
Cicatrix
1
2011
39
0.020
Why?
Microscopy, Phase-Contrast
1
2010
13
0.020
Why?
Plant Lectins
1
2010
8
0.020
Why?
Glycosylation
1
2010
103
0.020
Why?
Substrate Specificity
1
2010
190
0.020
Why?
Actins
1
2010
112
0.020
Why?
Tumor Cells, Cultured
1
2010
453
0.020
Why?
Cell Movement
1
2010
244
0.020
Why?
Breast Neoplasms, Male
1
2009
4
0.020
Why?
Pilot Projects
1
2011
694
0.020
Why?
Arm
1
2008
47
0.020
Why?
Phenotype
1
2010
736
0.020
Why?
Cost-Benefit Analysis
1
2008
263
0.020
Why?
Positron-Emission Tomography
1
2008
290
0.020
Why?
Administration, Rectal
1
2006
10
0.020
Why?
Cell Line, Tumor
1
2010
1393
0.020
Why?
Probability
1
2006
163
0.020
Why?
Primary Prevention
1
2006
44
0.020
Why?
Drug Administration Schedule
1
2006
373
0.020
Why?
Administration, Oral
1
2006
438
0.010
Why?
Carcinoma, Ductal
1
2004
7
0.010
Why?
Tissue Expansion
1
2004
4
0.010
Why?
Pectoralis Muscles
1
2004
5
0.010
Why?
Spasm
1
2004
9
0.010
Why?
Rectus Abdominis
1
2004
10
0.010
Why?
Multivariate Analysis
1
2006
583
0.010
Why?
Laser Coagulation
1
2004
26
0.010
Why?
Cryosurgery
1
2004
36
0.010
Why?
Sampling Studies
1
2004
36
0.010
Why?
Statistics, Nonparametric
1
2004
189
0.010
Why?
Chi-Square Distribution
1
2004
275
0.010
Why?
Injections
1
2003
58
0.010
Why?
Pain Measurement
1
2004
271
0.010
Why?
Ultrasonography
1
2004
434
0.010
Why?
Dose-Response Relationship, Drug
1
2006
1369
0.010
Why?
Length of Stay
1
2004
631
0.010
Why?
Reoperation
1
2002
461
0.010
Why?
Analgesics, Opioid
1
2004
577
0.010
Why?
Henry-Tillman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description